UiPath’s fourth quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, but the market responded negatively as concerns emerged around the sustainability of growth and the evolving automation landscape. Management pointed to robust enterprise adoption of its agentic automation platform, particularly AI-driven solutions, and highlighted strong sequential gains in large customer deals. CEO Daniel Dines emphasized, “We posted our strongest sequential net additions of customers with $1 million or more in ARR in 2 years,” crediting improved sales execution and deepening platform adoption across key verticals such as healthcare and financial services.
Is now the time to buy PATH? Find out in our full research report (it’s free for active Edge members).
UiPath (PATH) Q4 CY2025 Highlights:
- Revenue: $481.1 million vs analyst estimates of $464.8 million (13.6% year-on-year growth, 3.5% beat)
- Adjusted EPS: $0.30 vs analyst estimates of $0.25 (17.8% beat)
- Adjusted Operating Income: $150.1 million vs analyst estimates of $139.8 million (31.2% margin, 7.3% beat)
- Revenue Guidance for Q1 CY2026 is $397.5 million at the midpoint, roughly in line with what analysts were expecting
- Operating Margin: 16.7%, up from 7.9% in the same quarter last year
- Annual Recurring Revenue: $1.85 billion vs analyst estimates of $1.85 billion (11.2% year-on-year growth, in line)
- Billings: $555.3 million at quarter end, up 14.4% year on year
- Market Capitalization: $6.41 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From UiPath’s Q4 Earnings Call
- Bryan Bergin (TD Cowen) asked about net new ARR expansion and FX headwinds. CFO Ashim Gupta explained that FX impact should be minimal and emphasized stable expansion in large customer cohorts.
- Sanjit Singh (Morgan Stanley) questioned the momentum of AI product ARR, specifically the split between IDP and agentic products. CEO Daniel Dines stated they don’t disclose splits but confirmed agentic is a significant and growing portion.
- Michael Turrin (Wells Fargo Securities) probed on competitive positioning as more vendors enter agentic AI. Dines responded that UiPath’s unique orchestration and integration of deterministic and agentic automation differentiates it, especially for complex enterprise needs.
- Chirag Ved (Evercore ISI) inquired about vertical strength and the repeatability of agentic automation sales cycles. Dines highlighted healthcare, financial services, and public sector as most receptive, and noted vertical solutions are still early but expanding.
- Phil Winslow (Mizuho Securities) asked about the path to the new long-term margin target. Gupta cited ongoing productivity improvements and internal agentic deployments as primary drivers for the higher margin goal.
Catalysts in Upcoming Quarters
Moving forward, the StockStory team will closely monitor (1) the pace of AI-driven automation adoption within large enterprise accounts, (2) the effectiveness of newly launched vertical solutions in healthcare and financial services, and (3) margin progression as internal productivity initiatives and cost discipline are executed. Execution on product roadmap milestones—particularly around Maestro orchestration and coding agents—will also be important signposts.
UiPath currently trades at $11.97, down from $12.38 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
Our Favorite Stocks Right Now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
